SCHEMBL3977919

SCHEMBL3977919

Cn1nccc1-c1cc(C(N)=O)ccc1OCC[AsH2]

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 20/20 0.52
HTR2C P28335 14/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3904874 0.89 HTR2A (0.63) HTR2AHTR2C
SCHEMBL4697766 0.88 HTR2A (0.52) HTR2AHTR2C
SCHEMBL4695188 0.84 HTR2A (0.64) HTR2AHTR2C
SCHEMBL4699244 0.84 HTR2A (0.65) HTR2AHTR2C
SCHEMBL4697101 0.83 HTR2A (0.67) HTR2AHTR2C
Trifluoroacetic Acid SCHEMBL2064581 0.83 HTR2A (0.58) HTR2AHTR2C
SCHEMBL3908797 0.83 HTR2A (0.46) HTR2AHTR2C
SCHEMBL3903995 0.83 HTR2A (0.46) HTR2AHTR2C
SCHEMBL4695970 0.82 HTR2A (0.65) HTR2AHTR2C
SCHEMBL3977925 0.82 HTR2A (0.45) HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2018371-A1 PRIMARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2009-01-28 EP claimed
WO-2007136703-A1 PRIMARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-11-29 WO claimed